ABT-431, a selective D1 agonist has efficacy in patients with Parkinson's disease

被引：0
|
作者：
Rascol, O
Blin, O
Descombes, S
Soubrouilliard, C
Fabre, N
Viallet, F
Thalamas, C
Azulay, JP
Lafnitzegger, K
Fredrick, E
Wright, S
Nutt, J
机构：
来源：
NEUROLOGY | 1997年 / 48卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：32004 / 32004
页数：2
相关论文
共 50 条
  • [1] ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease
    Rascol, O
    Blin, O
    Thalamas, C
    Descombes, S
    Soubrouillard, C
    Azulay, P
    Fabre, N
    Viallet, F
    Lafnitzegger, K
    Wright, S
    Carter, JH
    Nutt, JG
    [J]. ANNALS OF NEUROLOGY, 1999, 45 (06) : 736 - 741
  • [2] Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease
    Rascol, O
    Nutt, JG
    Blin, O
    Goetz, CG
    Trugman, JM
    Soubrouillard, C
    Carter, JH
    Currie, LJ
    Fabre, N
    Thalamas, C
    Giardina, WJ
    Wright, S
    [J]. ARCHIVES OF NEUROLOGY, 2001, 58 (02) : 249 - 254
  • [3] A double blind comparison of ABT-431, a selective, full dopamine D1 receptor agonist, with levodopa in the treatment of advanced Parkinson's disease
    Rascol, O
    Blin, O
    Wright, S
    Lafnitzegger, K
    Thalamas, C
    Senard, A
    Descombes, S
    Gu, X
    Soubrouillard, C
    Azulay, JP
    Viallet, F
    [J]. NEUROLOGY, 1998, 50 (04) : A70 - A70
  • [4] Efficacy of dopamine D1 receptor agonists A-86929 and ABT-431 in animal models of Parkinson's disease
    Shiosaki, K
    Asin, KE
    Bedard, P
    Britton, DR
    Jenner, P
    Lin, CW
    Michaelides, M
    Williams, M
    [J]. DOPAMINE RECEPTOR SUBTYPES: FROM BASIC SCIENCE TO CLINICAL APPLICATION, 1998, 19 : 84 - 97
  • [5] ABT-431 -: Adrogolide hydrochloride -: Dopamine D1 agonist -: Antiparkinsonian
    不详
    [J]. DRUGS OF THE FUTURE, 2000, 25 (08) : 844 - 844
  • [6] Adrogolide hydrochloride -: ABT-431 -: Antiparkinsonian -: Dopamine D1 agonist
    不详
    [J]. DRUGS OF THE FUTURE, 2001, 26 (08) : 795 - 795
  • [7] Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self administration in humans
    Haney, M
    Collins, ED
    Ward, AS
    Foltin, RW
    Fischman, MW
    [J]. PSYCHOPHARMACOLOGY, 1999, 143 (01) : 102 - 110
  • [8] Comparison of efficacy and dyskinesia-inducing potential of levodopa and ABT-431, a selective, full dopamine D1 receptor agonist
    Wright, S
    Nutt, J
    Goetz, C
    Trugman, J
    Carter, J
    Felbel, J
    Lafnitzegger, K
    [J]. NEUROLOGY, 1998, 50 (04) : A135 - A135
  • [9] Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans
    M. Haney
    Eric D. Collins
    Amie S. Ward
    Richard W. Foltin
    Marian W. Fischman
    [J]. Psychopharmacology, 1999, 143 : 102 - 110
  • [10] Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement
    Self, DW
    Karanian, DA
    Spencer, JJ
    [J]. NEW MEDICATIONS FOR DRUG ABUSE, 2000, 909 : 133 - 144
12345